Y-mAbs Therapeutics, Inc. Uncategorized Contracts & Agreements
7 Contracts & Agreements
- Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 30, 2023)
- Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 1, 2022)
- Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 1, 2021)
- Master Sponsored Research Agreement effective as of October 7, 2020 by and between the Company and Memorial Sloan Kettering Cancer Center (Filed With SEC on October 8, 2020)
- Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 12, 2020)
- Y-mAbs Sublicense Agreement, dated as of June 27, 2018, by and between the Company and MabVax Therapeutics Holdings, Inc (Filed With SEC on December 19, 2019)
- Amended and Restated Sponsored Research Agreement effective as of September 13, 2019 by and between the Company and Memorial Sloan Kettering Cancer Center (Filed With SEC on September 19, 2019)